PER 0.00% 10.5¢ percheron therapeutics limited

Sarepta FDA Hearing, page-37

  1. 13,421 Posts.
    lightbulb Created with Sketch. 1439
    Hi Joe
    Nothing has changed
    We are in the Non Ambulant space with DMD and Limb girdle R2
    Sarepta has limb girdle but not R2 science
    If we only have DMD in Europe it’s still a $5 stock
    Sarepta can’t market their Dmd drugs in Europe
    FDA has set a prcedent. ( no need to show efficacy and safety data )
    So we just have to replicate the end points pUL -2
    and we should be able to market our drugs in Europe and USA..
    Last edited by itsagas: 13/05/23
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $94.66M
Open High Low Value Volume
10.5¢ 10.5¢ 9.8¢ $58.09K 574.8K

Buyers (Bids)

No. Vol. Price($)
1 38503 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 194063 5
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.